Abstract
ObjectiveTo study the effect of gastroesophageal reflux disease (GERD) management by using high dose of proton pump inhibitors (PPIs) on the outcome of uncontrolled asthma. Study designThe study included 100 patients with their ages ranging from 21 to 69years. They presented with uncontrolled asthma (FEV1 less than 80%, with daily rescue medications and more than one urgent care visit/year). And all patients were on high dose of inhaled oral corticosteroid (more than 880μg fluticasone).F-scale questionnaire was done for the diagnosis of GERD.Patients with GERD and bronchial asthma received PPIs (40mg omeprazole) and inhaled oral corticosteroid (500μg fluticasone with long acting beta-2 agonist 100μg salmeterol) for 3months. ResultsThirty-one (31%) patients showed combined GERD and bronchial asthma. Twenty-three patients showed significant improvement in asthma control after combined therapy (p value 0.01).Twenty-three patients showed significant improvement in lung function (FEV1 more than 80%), maintained moderate dose of inhaled corticosteroid without rescue medication (p value 0.01). ConclusionGERD is an important cause of uncontrolled asthma and its management significantly improves the uncontrolled asthma and significantly reduces the inhaled oral corticosteroid.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Egyptian Journal of Chest Diseases and Tuberculosis
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
